- Home
- AMC vs CLDX Comparison
AMC vs CLDX Comparison
Compare AMC & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMC
- CLDX
- Stock Information
- Founded
- AMC 1920
- CLDX N/A
- Country
- AMC United States
- CLDX United States
- Employees
- AMC N/A
- CLDX N/A
- Industry
- AMC Movies/Entertainment
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- AMC Consumer Discretionary
- CLDX Health Care
- Exchange
- AMC Nasdaq
- CLDX Nasdaq
- Market Cap
- AMC 1.5B
- CLDX 1.3B
- IPO Year
- AMC 2013
- CLDX 2008
- Fundamental
- Price
- AMC $3.01
- CLDX $20.50
- Analyst Decision
- AMC Hold
- CLDX Buy
- Analyst Count
- AMC 7
- CLDX 9
- Target Price
- AMC $3.92
- CLDX $50.00
- AVG Volume (30 Days)
- AMC 13.7M
- CLDX 1.2M
- Earning Date
- AMC 08-01-2025
- CLDX 08-07-2025
- Dividend Yield
- AMC N/A
- CLDX N/A
- EPS Growth
- AMC N/A
- CLDX N/A
- EPS
- AMC N/A
- CLDX N/A
- Revenue
- AMC $4,548,300,000.00
- CLDX $7,559,000.00
- Revenue This Year
- AMC $8.36
- CLDX N/A
- Revenue Next Year
- AMC $6.63
- CLDX N/A
- P/E Ratio
- AMC N/A
- CLDX N/A
- Revenue Growth
- AMC N/A
- CLDX 24.49
- 52 Week Low
- AMC $2.45
- CLDX $14.40
- 52 Week High
- AMC $5.76
- CLDX $47.00
- Technical
- Relative Strength Index (RSI)
- AMC 43.56
- CLDX 52.11
- Support Level
- AMC $3.08
- CLDX $19.77
- Resistance Level
- AMC $3.54
- CLDX $24.03
- Average True Range (ATR)
- AMC 0.13
- CLDX 1.31
- MACD
- AMC -0.06
- CLDX -0.00
- Stochastic Oscillator
- AMC 5.17
- CLDX 26.15
About AMC AMC Entertainment Holdings Inc.
AMC Entertainment Holdings Inc is involved in the theatrical exhibition business. It owns, operates, or has interests in theatres located in the United States and Europe. It provides amenities such as plush, power recliners, MacGuffins full bars, AMC Dine-In Theatres, and premium presentation. The company has identified two reportable segments and reporting units for its theatrical exhibition operations, U.S. markets and International markets. It derives key revenue from the U.S.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.